Artialis: Passion for Healthy Aging
Artialis, a leading Contract Research Development Organization (CRDO), specializes in musculoskeletal health. Offering a comprehensive range of services from preclinical research to post-marketing surveillance.
Founded in 2010, Artialis emerged from the University of Liege’s Bone and Cartilage Research Unit. With a strong foundation in scientific research, Artialis has grown into a trusted partner for pharmaceutical and biotech companies worldwide.
Over the past 14 years, Artialis has successfully completed 142 R&D projects, leveraging the combined expertise of its team, which boasts over 75 years of experience in the industry. This wealth of knowledge allows Artialis to provide tailored solutions and navigate the complexities of product development.
Driven by a commitment to client satisfaction, the company has achieved a remarkable 90% satisfaction rate.
Lear more: www.artialis.com
A LEADING POSITION AND
AN INTERNATIONAL DEPLOYMENT
64 +
countries
involved
20 000 +
investigational
Centres
3 million +
patients
in database
50 000 +
users
worlwide
LATEST NEWSOUR NEWS >
October 30, 2025
February 1–3, 2025 – Amsterdam | Booth 16-17-18 We’re excited to announce our participation to EUCROF26! Visit our booth to explore CleanWeb™, our advanced eClinical suite for managing clinical trials, registries, and early access programs. Together with our CRO Alliance partners (BlueCompanion, Clinica Group, DeltaClinical, NextCRO, Phoenix CR), we offer tailored solutions to support your […]
October 30, 2025
Applied Clinical Trials Online Clinical trials have traditionally relied on paper-based consent forms to secure the participant’s approval. While this approach is still common in many studies, it presents practical challenges. Participants may struggle with dense medical jargon, documents can be misplaced, and re-consenting often adds to site workload. As decentralized and hybrid trial models […]
October 30, 2025
Biopharm International To improve patient outcomes, experience, and engagement, patient-centric drug development is essential. By focusing on patients’ needs, experiences, and preferences, drug developers can create treatments that are optimally effective and tolerated. This leads to improved adherence to treatment regimens and better overall health outcomes when compared with not taking these factors into consideration […]